Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-20 Sale |
2024-05-21 5:55 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
11,610 | $11.76 | $136,586 | 123,430 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 9:51 pm |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. CHIEF SCIENTIFIC OFFICER |
28,288 | $14.07 | $397,929 | 124,302 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 9:48 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
12,053 | $14.11 | $170,124 | 142,332 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 9:46 pm |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO |
22,802 | $14.11 | $321,846 | 341,030 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 9:44 pm |
KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER |
14,295 | $14.12 | $201,774 | 151,184 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 9:41 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
24,888 | $14.11 | $351,289 | 395,394 (Direct) |
View |
| 2024-02-14 Sale |
2024-02-16 4:21 pm |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO |
40,855 | $15.01 | $613,205 | 159,088 (Direct) |
View |
| 2024-02-14 Sale |
2024-02-16 4:20 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
58,356 | $15.01 | $875,883 | 181,676 (Direct) |
View |
| 2024-02-14 Sale |
2024-02-16 4:19 pm |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. CHIEF SCIENTIFIC OFFICER |
28,171 | $15.01 | $422,827 | 71,657 (Direct) |
View |
| 2024-02-14 Sale |
2024-02-16 4:18 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
39,886 | $15.01 | $598,661 | 66,160 (Direct) |
View |
| 2024-02-06 Purchase |
2024-02-08 8:11 pm |
KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. Koh Bong Y VHCP Co-Investment Holdings III LLC VHCP Management III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. Shah Nimish P 10% Owner |
86,048 | $14.62 | $1,257,829 | 4,824,731 (Indirect) |
View |
| 2024-02-01 Sale |
2024-02-05 5:55 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
10,000 | $16.22 | $162,198 | 117,532 (Direct) |
View |
| 2024-01-30 Purchase |
2024-02-01 4:38 pm |
KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. Koh Bong Y VHCP Co-Investment Holdings III LLC VHCP Management III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. Shah Nimish P 10% Owner |
88,099 | $14.47 | $1,274,793 | 4,738,683 (Indirect) |
View |
| 2024-01-25 Purchase |
2024-01-29 7:07 pm |
KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. Koh Bong Y VHCP Co-Investment Holdings III LLC VHCP Management III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. Shah Nimish P 10% Owner |
91,804 | $14.05 | $1,289,802 | 4,650,584 (Indirect) |
View |
| 2024-01-22 Purchase |
2024-01-24 8:24 pm |
KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. Koh Bong Y VHCP Co-Investment Holdings III LLC VHCP Management III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. Shah Nimish P 10% Owner |
99,129 | $12.53 | $1,241,685 | 4,558,780 (Indirect) |
View |
| 2024-01-17 Purchase |
2024-01-19 6:02 pm |
KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management EG LLC Koh Bong Y Shah Nimish P 10% Owner |
143,605 | $12.55 | $1,801,602 | 4,459,651 (Indirect) |
View |
| 2024-01-11 Purchase |
2024-01-16 7:04 pm |
KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management EG LLC Koh Bong Y Shah Nimish P 10% Owner |
26,246 | $12.72 | $333,779 | 4,316,046 (Indirect) |
View |
| 2024-01-11 Sale |
2024-01-12 4:26 pm |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
22,679 | $13.03 | $295,514 | 39,828 (Direct) |
View |
| 2024-01-08 Purchase |
2024-01-10 8:57 pm |
KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management EG LLC Koh Bong Y Shah Nimish P 10% Owner |
137,700 | $12.54 | $1,726,457 | 4,289,800 (Indirect) |
View |
| 2024-01-08 Sale |
2024-01-10 6:05 pm |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
17,321 | $13.01 | $225,300 | 62,507 (Direct) |
View |
| 2024-01-03 Purchase |
2024-01-05 4:13 pm |
KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management EG LLC Koh Bong Y Shah Nimish P 10% Owner |
59,369 | $12.14 | $720,543 | 4,152,100 (Indirect) |
View |
| 2023-12-27 Purchase |
2023-12-29 6:44 pm |
KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management EG LLC Koh Bong Y Shah Nimish P 10% Owner |
519,017 | $12.46 | $6,465,650 | 4,092,731 (Indirect) |
View |
| 2023-12-27 Sale |
2023-12-28 4:28 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
30,000 | $12.02 | $360,453 | 127,532 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 4:34 pm |
KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer |
7,985 | $8.2293 | $65,711 | 92,979 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 4:33 pm |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
4,958 | $8.2293 | $40,801 | 117,010 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 4:32 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
7,113 | $8.2293 | $58,535 | 83,228 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 4:31 pm |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y |
13,008 | $8.2293 | $107,047 | 192,187 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 4:30 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
14,807 | $8.2293 | $121,851 | 271,138 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-17 Exercise |
2024-05-21 5:55 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
37,578 | $0 | 123,430 (Direct) |
View |
| 2024-04-18 Option Award |
2024-04-22 4:35 pm |
N/A 2034-04-17 |
KalVista Pharmaceuticals Inc. | KALV | Fairey William Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2024-03-06 Option Award |
2024-03-08 4:50 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER |
250,000 | $0 | 250,000 (Direct) |
View |
| 2024-02-17 Exercise |
2024-02-21 9:51 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. CHIEF SCIENTIFIC OFFICER |
37,576 | $0 | 124,302 (Direct) |
View |
| 2024-02-17 Exercise |
2024-02-21 9:48 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
37,576 | $0 | 142,332 (Direct) |
View |
| 2024-02-17 Exercise |
2024-02-21 9:46 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO |
102,058 | $0 | 341,030 (Direct) |
View |
| 2024-02-17 Exercise |
2024-02-21 9:44 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER |
61,226 | $0 | 151,184 (Direct) |
View |
| 2024-02-17 Exercise |
2024-02-21 9:41 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
108,830 | $0 | 395,394 (Direct) |
View |
| 2024-02-11 Option Award |
2024-02-13 09:23 am |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO, CBO |
170,833 | $0 | 283,276 (Direct) |
View |
| 2024-02-11 Option Award |
2024-02-13 09:20 am |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. CHIEF SCIENTIFIC OFFICER |
89,167 | $0 | 128,995 (Direct) |
View |
| 2024-02-11 Option Award |
2024-02-13 09:11 am |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
89,167 | $0 | 135,213 (Direct) |
View |
| 2024-02-11 Option Award |
2024-02-13 09:08 am |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
205,833 | $0 | 323,365 (Direct) |
View |
| 2024-02-11 Option Award |
2024-02-13 09:06 am |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER |
48,333 | $0 | 48,333 (Direct) |
View |
Ownership |
2023-12-28 4:28 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management EG LLC Koh Bong Y Shah Nimish P 10% Owner |
0 | $0 | 3,573,714 (Indirect) |
View |
| 2023-11-17 Exercise |
2023-11-21 4:34 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. Chief Medical Officer |
37,060 | $0 | 92,979 (Direct) |
View |
| 2023-11-17 Exercise |
2023-11-21 4:33 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
22,994 | $0 | 117,010 (Direct) |
View |
| 2023-11-17 Exercise |
2023-11-21 4:32 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
22,994 | $0 | 83,228 (Direct) |
View |
| 2023-11-17 Exercise |
2023-11-21 4:31 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L President, CFO, CBO & Sec'y |
60,394 | $0 | 192,187 (Direct) |
View |
| 2023-11-17 Exercise |
2023-11-21 4:30 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
67,166 | $0 | 271,138 (Direct) |
View |
| 2023-10-30 Gift |
2023-11-01 4:12 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
8,000 | $0 | 138,756 (Direct) |
View |
| 2023-09-26 Option Award |
2023-09-28 4:55 pm |
N/A 2033-09-25 |
KalVista Pharmaceuticals Inc. | KALV | Treanor Patrick Director |
10,000 | $0 | 10,000 (Direct) |
View |